|
Originally published In Press as doi:10.1074/jbc.M207631200 on February 25, 2003
J. Biol. Chem., Vol. 278, Issue 19, 17360-17367, May 9, 2003
Expression of Galectin-3 in Skeletal Tissues Is Controlled by
Runx2*
Michael
Stock §,
Henning
Schäfer ,
Sigmar
Stricker¶,
Gerhard
Gross ,
Stefan
Mundlos¶, and
Florian
Otto **
From the Division of Hematology/Oncology, Medical
Center and the § Institute for Biology I, University of
Freiburg, 79106 Freiburg, Germany, the ¶ Max Planck Institute for
Molecular Genetics, 14195 Berlin, Germany, and the
Gesellschaft für Biotechnologische Forschung,
38124 Braunschweig, Germany
The -galatoside-specific lectin galectin-3 is
expressed in vivo in osteoblasts as well as in epiphyseal
cartilage. Here we show that in vitro, galectin-3
expression is up-regulated in the preosteoblastic cell line MC3T3-E1
during the matrix maturation stage of the osteoblast
developmental sequence. Expression persists into late
differentiation stages when the mature osteoblastic phenotype is
established. The skeletal expression pattern of galectin-3 overlaps at
many sites with that of the transcription factor Runx2. Runx2 is a key
regulator of osteoblast development and necessary for chondrocyte
differentiation in the growth plate. Both human and mouse galectin-3
promoters contain putative Runx-binding sites. The constitutive or
inducible forced expression of Runx2 is sufficient for the onset of
galectin-3 transcription in the mesenchymal precursor cell line
C3H10T1/2. Moreover, Runx2 is able to bind to at least two sites
in the galectin-3 promoter region. The crucial role of Runx2 was
confirmed in Runx2-deficient mice, which are devoid of galectin-3
expression in skeletal cells. The overlapping expression pattern of
galectin-3 with the other two members of the Runt family of
transcription factors (Runx1 and Runx3) points to a potential regulation of the galectin-3 gene (LGALS3) by these factors
in hematopoietic, skin, and dorsal root ganglial cells.
*
This work was supported by Deutsche Forschungsgemeinschaft
Grant DFG 134/2-2 (to F. O.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Div. of
Hematology/Oncology, University of Freiburg Medical Center, Hugstetter Strasse 55, D-79106 Freiburg, Germany. Tel.: 49-761-270-7357; Fax: 49-761-270-7177; E-mail: otto@mm11.ukl.uni-freiburg.de.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Kasper, L. Mao, S. Geissler, A. Draycheva, J. Trippens, J. Kuhnisch, M. Tschirschmann, K. Kaspar, C. Perka, G. N. Duda, et al.
Insights into Mesenchymal Stem Cell Aging: Involvement of Antioxidant Defense and Actin Cytoskeleton
Stem Cells,
June 1, 2009;
27(6):
1288 - 1297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Kantawong, R. Burchmore, N. Gadegaard, R. O.C Oreffo, and M. J Dalby
Proteomic analysis of human osteoprogenitor response to disordered nanotopography
J R Soc Interface,
February 9, 2009;
(2009)
rsif.2008.0447v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Surmann-Schmitt, U. Dietz, T. Kireva, N. Adam, J. Park, A. Tagariello, P. Onnerfjord, D. Heinegard, U. Schlotzer-Schrehardt, R. Deutzmann, et al.
Ucma, a Novel Secreted Cartilage-specific Protein with Implications in Osteogenesis
J. Biol. Chem.,
March 14, 2008;
283(11):
7082 - 7093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ortega, D. J. Behonick, C. Colnot, D. N.W. Cooper, and Z. Werb
Galectin-3 Is a Downstream Regulator of Matrix Metalloproteinase-9 Function during Endochondral Bone Formation
Mol. Biol. Cell,
June 1, 2005;
16(6):
3028 - 3039.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|